Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Avhandlingar

2025

  • Immune Response in Triple-Negative Breast Cancer-Machine Learning-based Insights from Histology and-Omics, Suze Roostee - 25 feb 2025

2024

  • Selenoproteins as predictors of prognosis after breast cancer diagnosis, Kamil Demircan - 29 nov 2024
  • Regulation of estrogen receptor alpha by promoter methylation, alternative splicing and microRNA, Juliane Albrecht - 23 okt 2024
  • Metabolic and angiogenic biomarkers in breast cancer: potential clinical implications of host–tumor interactions, Christopher Godina - 18 jun 2024
  • Decoding pan-cancer complexity. Multiomic insights from the lung and breast, Deborah Figueiredo Nacer de Oliveira - 18 jun 2024
  • Precision Medicine in Breast Cancer: A Molecular Genomics and Diagnostics Approach, Heena Dalal - 17 jun 2024
  • Gene fusions and microRNAs in cancer, Völundur Hafstað - 13 jun 2024
  • Aspects of breast-conserving surgery, Kim Gulis - 22 mar 2024

2021

  • RNA sequencing for molecular diagnostics in breast cancer, Christian Brüffer - 13 jan 2017

2018

  • Predictors of lymph node metastasis in primary breast cancer - risk models for tailored axillary management, Looket Dihge 27 april 2018

2017

  • Treatment of BRCA 1/2-associated breast cancer and identification of mutation carriers among breast cancer patients, Martin Nilsson - 15 jun 2017